Somaterapija, MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statement report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
4,371 |
- |
2,749 |
2,610 |
- |
94.05 |
59.71 |
2,619 |
1,314 |
680 |
3,239 |
2022 |
---|
2,030 |
- |
-913 |
-913 |
- |
75.62 |
-44.98 |
1,706 |
1,343 |
503 |
2,505 |
2023 |
---|
5,870 |
- |
-306 |
-306 |
- |
100.00 |
-5.21 |
1,400 |
1,662 |
326 |
2,702 |
Register and
explore Okredo dataRegister and
explore Okredo data2023
Turnover (€)
5,870 €189 % *
Sales per employee (€)
-Profit before tax (€)
-306 €66 % *
Net Profit (€)
-306 €66 % *
Profit per employee (€)
-Total profitability (%)
100.00 %32.24 % *
Net profitability (%)
-5.21 %88.42 % *
Equity (€)
1,400 €-18 % *
Amounts Payable And Liabilities (€)
1,662 €24 % *
Non-current Assets (€)
326 €-35 % *
CurrentAssets (€)
2,702 €8 % *